May 7th 2024
By The Center for Biosimilars Staff
Dive into biosimilar regulations in the US! Test your knowledge with our quiz on FDA rules, naming tricks, postmarket safety, and more. Ready for the challenge?
April 2nd 2024
Have you been keeping up with the latest market trends? Take this quiz to find out how well you know the global biosimilars market.
March 1st 2024
Explore the dynamic world of global biosimilar markets and policies! What do you know about the international biosimilar industry?
February 9th 2024
Test your knowledge of major biosimilar policies, including challenging regulatory frameworks from around the world.
January 8th 2024
Intro to Biosimilars is now in session! Test yourself on how well you know these biosimilar basics.
December 23rd 2021
By Tony Hagen
In Canada, a new jurisdiction inaugurates mandatory switching to biosimilars.
December 16th 2021
Alvotech has received European Commission (EC) approval to begin marketing its adalimumab biosimliar AVT02, the company announced this week.
June 23rd 2021
Diverse findings on biosimilar safety and savings were presented at the American Society for Clinical Oncology (ASCO) 2021 Annual Meeting.
June 8th 2021
Reverse switching occurs when patients transitioned to or initiated on a biosimilar are changed to an originator product, often because of a perceived failure in the biosimilar therapy.
May 12th 2021
When it comes to biologics, there is a constant push and pull over patent rights. Some believe this is part of a healthy market-driven economy. Others are skeptical.
